ArticleTheranostics2020
Cancer immunotherapy is accompanied by distinct metabolic patterns in primary and secondary lymphoid organs observed by non-invasive
Open access · goldAbstract read
In one paragraph
Article in Theranostics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.
0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.0field-weighted citation impact, top 7% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 61 citations in OpenAlex.
- [Cancer imaging : the official publication of the International Cancer Imaging Society · 2026Article
- Prognostic Value ofJournal of clinical medicine · 2026Article
- Noninvasive in vivo deoxycytidine kinase (dCK)-PET identifies tumor-draining lymph nodes upon immune checkpoint inhibitor therapy.Npj imaging · 2026Article
- Tumor-Induced Rewiring of Splenic Niches: from Immune Organ to Cancer Accomplice.International journal of biological sciences · 2026Review
- Cryo-trojan mesenchymal stem cells as non-living tumor-homing supercarriers for enhanced drug delivery and immune activation in prostate cancer.Materials today. Bio · 2025Article
- BaselineLa Radiologia medica · 2025Article
- The Combined Prognostic Value ofCancer medicine · 2025Article
- [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024Article
- Transferrin receptor-targeted immunostimulant for photodynamic immunotherapy against metastatic tumors throughActa pharmaceutica Sinica. B · 2024Article
- Article
- Does high [European radiology · 2023Article
- Advances in PET imaging of cancer.Nature reviews. Cancer · 2023Review
- Metabolic patterns on [European journal of nuclear medicine and molecular imaging · 2023Article
- Preclinical Identification Of Tumor-Draining Lymph Nodes Using a Multimodal Non-invasive In vivo Imaging Approach.Molecular imaging and biology · 2023Article
- Positron emission tomography molecular imaging to monitor anti-tumor systemic response for immune checkpoint inhibitor therapy.European journal of nuclear medicine and molecular imaging · 2023Review
- Imaging glucose metabolism to reveal tumor progression.Frontiers in physiology · 2023Review
- Article
- Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy.Cancer imaging : the official publication of the International Cancer Imaging Society · 2022Article
- Article
- A role for artificial intelligence in molecular imaging of infection and inflammation.European journal of hybrid imaging · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors at 6 institutions in 2 countries.
Johannes SchwenckDepartment of Nuclear Medicine and Clinical Molecular Imaging, Eberhard Karls University, 72076 Tübingen, Germany.
Barbara SchörgWerner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, 72076 Tübingen, Germany.
Francesco FizDepartment of Nuclear Medicine and Clinical Molecular Imaging, Eberhard Karls University, 72076 Tübingen, Germany.
Dominik SonaniniWerner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, 72076 Tübingen, Germany.
Andrea ForschnerDepartment of Dermatology, Eberhard Karls University, 72076 Tübingen, Germany.
Thomas EigentlerDepartment of Dermatology, Eberhard Karls University, 72076 Tübingen, Germany.
Benjamin WeideDepartment of Dermatology, Eberhard Karls University, 72076 Tübingen, Germany.
Manuela MartellaInstitute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen, Eberhard Karls University, 72076 Tübingen, Germany.
Irene Gonzalez-MenendezCluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University, 72076 Tübingen, Germany.
Cristina CampiDepartment of Mathematics "Tullio Levi-Civita", University of Padua, Italy.
Gianmario SambucetiNuclear Medicine Unit, Department of Health Sciences, University of Genoa, Italy.
Ferdinand SeithDepartment of Diagnostic and Interventional Radiology, Eberhard Karls University, 72076 Tübingen, Germany.
Leticia Quintanilla-MartinezCluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University, 72076 Tübingen, Germany.
Claus GarbeDepartment of Dermatology, Eberhard Karls University, 72076 Tübingen, Germany.
Christina PfannenbergDepartment of Diagnostic and Interventional Radiology, Eberhard Karls University, 72076 Tübingen, Germany.
Martin RöckenCluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University, 72076 Tübingen, Germany.
Christian la FougereDepartment of Nuclear Medicine and Clinical Molecular Imaging, Eberhard Karls University, 72076 Tübingen, Germany.
Bernd J PichlerWerner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, 72076 Tübingen, Germany.
Manfred KneillingWerner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, 72076 Tübingen, Germany.
University of Tübingen · DEBernstein Center for Computational Neuroscience Tübingen · DEGerman Cancer Research Center · DESiemens (Germany) · DEUniversity of Genoa · ITCivita · IT
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
AnimalsBiomarkers, TumorDisease Models, AnimalFluorodeoxyglucose F18HumansImmunotherapyLymphoid TissueMelanomaMiceMice, Inbred C3HMice, TransgenicPancreatic NeoplasmsPositron Emission Tomography Computed TomographyRadiopharmaceuticalsRetrospective StudiesTreatment OutcomeBiomarkers, TumorFluorodeoxyglucose F18RadiopharmaceuticalsCheckpoint inhibitor therapyimaging of primary and secondary lymphatic organsPET/CTresponse assessment of immunotherapytranslational
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.